CRISPR Therapeutics director gets 75 shares

CRISPR Therapeutics director Ali Behbahani reported receiving shares via a pro rata distribution from a fund and a related trust on August 6, 2025.

Rhea-AI Filing Summary

CRISPR Therapeutics AG (symbol: CRSP) is the issuer of record for a Form 4 filing submitted to the SEC. Behbahani Ali reported acquisition or exercise transactions in this Form 4 filing.

CRISPR Therapeutics AG (CRSP) director Ali Behbahani reported receiving Common Shares through an entity restructuring transaction on August 6, 2025. A pro rata distribution by NEA Partners 15, L.P. transferred 60 Common Shares to him directly, bringing his directly held position to 316 Common Shares.

The same distribution transferred 15 Common Shares to The Ali Behbahani Revocable Trust Dated June 26, 2015, resulting in 29 Common Shares held indirectly. He serves as trustee of the trust and disclaims beneficial ownership of any trust shares in which he has no pecuniary interest. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Other: 75 shares

Other 2 txns

Insider Behbahani Ali

Role Director

Type	Security	Shares	Price	Value
Other	Common Shares F1	60	$0.00	$0.00
Other	Common Shares F2, F3	15	$0.00	$0.00

Holdings After Transaction: Common Shares — 316 shares (Direct); Common Shares — 29 shares (Indirect, See Note 3)

Footnotes (3)

1. F1. NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.
2. F2. The Ali Behbahani Revocable Trust Dated June 26, 2015 (the "Behbahani Trust") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.
3. F3. The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest.

Key Figures

Direct shares acquired: 60 Common Shares Direct holdings after transaction: 316 Common Shares Indirect shares acquired: 15 Common Shares +3 more

6 metrics

Direct shares acquired 60 Common Shares Received in a pro rata distribution from NEA Partners 15, L.P. on August 6, 2025

Direct holdings after transaction 316 Common Shares Total direct ownership of Ali Behbahani following the distribution

Indirect shares acquired 15 Common Shares Received by The Ali Behbahani Revocable Trust in the same distribution on August 6, 2025

Indirect holdings after transaction 29 Common Shares Total shares held through The Ali Behbahani Revocable Trust after the transaction

Reported transaction price per share $0.00 per share Both transactions coded as received for no consideration in a pro rata distribution

Restructuring shares 75 Common Shares Total shares involved in restructuring transactions reported in this Form 4

Key Terms

pro rata distribution, pecuniary interest, beneficial ownership, Section 16 of the Securities Exchange Act of 1934, +1 more

5 terms

pro rata distribution financial

"NEA Partners 15, L.P. made a pro rata distribution for no consideration"

A pro rata distribution is when a company or organization shares out money, assets, or benefits evenly among all eligible people based on their size or share. For example, if a company makes a profit and distributes it to shareholders, each person gets a portion proportional to how many shares they own. It ensures everyone gets their fair part based on their ownership or stake.

pecuniary interest financial

"disclaims beneficial ownership of such portion ... in which the Reporting Person has no pecuniary interest"

beneficial ownership regulatory

"disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Section 16 of the Securities Exchange Act of 1934 regulatory

"within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended"

A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.

indirect ownership financial

"The Behbahani Trust received 15 Common Shares ... reported as indirect ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CRSP director Ali Behbahani report on August 6, 2025?

He reported two restructuring transactions on August 6, 2025: 60 Common Shares received directly and 15 Common Shares received by a revocable trust in a pro rata distribution from NEA Partners 15, L.P., all at a reported price of $0.00 per share.

How many CRSP shares does Ali Behbahani hold directly after these transactions?

After the August 6, 2025 distribution, Ali Behbahani directly holds 316 Common Shares of CRISPR Therapeutics AG. This figure is reported as his total direct ownership following the transaction.

What are Ali Behbahani’s indirect holdings of CRSP shares after the Form 4 transactions?

Following the August 6, 2025 transaction, 29 Common Shares of CRISPR Therapeutics AG are reported as held indirectly through The Ali Behbahani Revocable Trust Dated June 26, 2015, with Behbahani as trustee.

How did Ali Behbahani acquire the reported CRSP shares, and was consideration paid?

The Form 4 states that NEA Partners 15, L.P. made a pro rata distribution for no consideration of Common Shares to its limited partners on August 6, 2025. Behbahani and his revocable trust received shares in that distribution.

Does Ali Behbahani disclaim any beneficial ownership of CRSP shares held through the trust?

Yes. The filing states that he disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, of the portion of CRSP Common Shares held by the revocable trust in which he has no pecuniary interest.

Were the reported CRSP transactions made under a Rule 10b5-1 trading plan?

No. The document-level checkbox indicates no Rule 10b5-1 trading plan applies to these transactions, and the footnotes do not describe any pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 06:30 PM Accepted by SEC EDGAR 09/21/2026 - 06:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Behbahani Ali

(Last) (First) (Middle)

2855 SAND HILL ROAD

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CRISPR Therapeutics AG [ CRSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/06/2025		J(1)		60	A	$0.00	316	D
Common Shares	08/06/2025		J(2)		15	A	$0.00	29	I	See Note 3(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.

2. The Ali Behbahani Revocable Trust Dated June 26, 2015 (the "Behbahani Trust") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.

3. The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest.

	/s/ Zachary Bambach, attorney-in-fact	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)